URA CEO Tom Hale joins Wealth! to explore how wearable technology could potentially help address rising healthcare costs. "If ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, and ŌURA, maker of the world’s leading smart ring, ...

URA, which is now valued at more than $5bn, is set to integrate Dexcom’s glucose capabilities with the Oura ring.

Dexcom and ŌURA have partnered to integrate Dexcom's glucose biosensing feature with the ŌURA Ring's health metrics to help ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Originally ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital ...

Dexcom is also making a $75 million strategic investment in ŌURA Series D funding, with ŌURA now valued at more than $5 billion. “Dexcom offers the most accurate glucose biosensing systems on ...

URA recently announced an agreement with Dexcom, and a new report says this focus on blood sugar monitoring could be a “major ...

Dexcom is also making a $75 million strategic investment in ŌURA Series D funding, with ŌURA now valued at more than $5 billion. This press release features multimedia. View the full release ...

SAN DIEGO & SAN FRANCISCO – Dexcom’s glucose data with be integrated with the Oura Ring’s vital sign, sleep, stress, heart health and activity data to provide users of both products with a more comple ...

Nov 19 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion. Ōura, ...

ŌURA Media Contact Kate Brinks 415-823-3121 [email protected] Source: DexCom, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect ...